CMU researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body. This first-of-its-kind method brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
The technique, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), has allowed the researchers to overcome many challenges associated with existing 3D bioprinting methods, and to achieve unprecedented resolution and fidelity using soft and living materials.
Each of the organs in the human body, such as the heart, is built from specialized cells that are held together by a biological scaffold called the extracellular matrix (ECM). This network of ECM proteins provides the structure and biochemical signals that cells need to carry out their normal function. However, until now it has not been possible to rebuild this complex ECM architecture using traditional biofabrication methods.
What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle.
Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering
“What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle,” says Adam Feinberg, a professor of biomedical engineering (BME) and materials science & engineering, whose lab performed this work. “By using MRI data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells.”
Over 4,000 patients in the United States are waiting for a heart transplant, while millions of others worldwide need hearts but are ineligible for the waitlist. The need for replacement organs is immense, and new approaches are needed to engineer artificial organs that are capable of repairing, supplementing, or replacing long-term organ function. Feinberg, who is a member of Carnegie Mellon’s Bioengineered Organs Initiative and the Next Manufacturing Center, is working to solve these challenges with a new generation of bioengineered organs that more closely replicate natural organ structures.
“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body,” explains Andrew Hudson, a BME Ph.D. student in Feinberg’s lab and co-first author on the paper. “What makes it so hard to 3D print, however, is that it starts out as a fluid—so if you try to print this in air it just forms a puddle on your build platform. So we’ve developed a technique that prevents it from deforming.”
The FRESH 3D bioprinting method developed in Feinberg’s lab allows collagen to be deposited layer-by-layer within a support bath of gel, giving the collagen a chance to solidify in place before it is removed from the support bath. With FRESH, the support gel can be easily melted away by heating the gel from room temperature to body temperature after the print is complete. This way, the researchers can remove the support gel without damaging the printed structure made of collagen or cells.
This method is truly exciting for the field of 3D bioprinting because it allows collagen scaffolds to be printed at the large scale of human organs. And it is not limited to collagen, as a wide range of other soft gels including fibrin, alginate, and hyaluronic acid can be 3D bioprinted using the FRESH technique, providing a robust and adaptable tissue engineering platform. Importantly, the researchers also developed open-source designs so that nearly anyone, from medical labs to high school science classes, can build and have access to low-cost, high-performance 3D bioprinters.
Looking forward, FRESH has applications in many aspects of regenerative medicine, from wound repair to organ bioengineering, but it is just one piece of a growing biofabrication field. “Really what we’re talking about is the convergence of technologies,” says Feinberg. “Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”
“It is important to understand that there are many years of research yet to be done,” adds Feinberg, “but there should still be excitement that we’re making real progress towards engineering functional human tissues and organs, and this paper is one step along that path.”
Learn more: 3D printing the human heart
The Latest on: 3D bioprinting
via Google News
The Latest on: 3D bioprinting
- The Case Against Tarveda: An Open Letter to Organovo Shareholderson January 21, 2020 at 4:00 am
Their interest in Organovo is driven by an interest in 3D bioprinting, and in fact they specifically run a fund focused on 3D printing. In their offices in New York City, a very large bull statue sits ...
- 3D Bioprinting Market 2020 Upcoming Trends, Share, Top manufactures analysis, Demand, Growth Drivers, and Future Outlook to 2029on January 17, 2020 at 7:26 am
Reportocean.com adds has announced the new market intelligence report on “3D Bioprinting Market 2020 Upcoming Trends, Share, Top manufactures analysis, Demand, growth, and Future Outlook to 2029” The ...
- Success: 3D Bioprinter in Space Prints With Human Heart Cellson January 15, 2020 at 4:30 am
While the 3D printer’s bio-ink contained cell types such as heart muscle cells, nerve cells and vascular cells, it notably did not contain the scaffolding materials or thickening agents normally ...
- 3D Systems Joins CollPlant in Regenerative Medicine Effortson January 14, 2020 at 7:53 am
3D Systems DDD recently partnered with CollPlant Biotechnologies CLGN to jointly develop tissue and scaffold bioprinting processes for third party companies, aiming to expedite the advancements in the ...
- 3D Systems teams with CollPlant on 3D bioprinting solutionson January 13, 2020 at 7:02 am
3D Systems has announced a collaboration with CollPlant Biotechnologies, a regenerative medicine company focused on 3D bioprinting of tissues and organs, to jointly develop tissue and scaffold ...
- 3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicineon January 13, 2020 at 5:13 am
and CollPlant Biotechnologies (NASDAQ: CLGN), announced signing a joint development agreement intended to play ...
- We are one step closer to 3D printing donor organs in outer spaceon January 10, 2020 at 9:50 am
You might call it a giant leap for 3D bioprinting: Human heart cells have been 3D printed on the International Space Station (ISS) and are making their way back to Earth this week inside a SpaceX ...
- 3D Bioprinting Industry Study, 2019-2025 - Leading Players are Organovo Holdings, 3D Systems, CELLINK, Stratasys, and CollPlanton January 10, 2020 at 6:42 am
DUBLIN, Jan. 10, 2020 /PRNewswire/ -- The "Global 3D Bioprinting Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global 3D bioprinting market is anticipated to grow ...
- 3D Cell Culture Market to Witness Robust Expansion by 2030 with Prominent Key Players: Lonza, 3D Biotek , Corning Incorporatedon January 10, 2020 at 1:43 am
On the basis of product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free cell culture, magnetic levitation & 3D bioprinting, and microfluidics-based 3D cell ...
- Aspect Biosystems raises $26 million CAD in Series A for 3D printing of human tissueson January 9, 2020 at 5:10 am
Aspect Biosystems, a biotechnology company that conducts 3D bioprinting of human tissues, has raised $26 million CAD ($20 million USD) for its Series A round of funding. The new capital marks the ...
via Bing News